Texas Capital Bancshares’s AbbVie ABBV Stock Holding History

Texas Capital Bancshares’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$31.5K	Buy	+136	New	+$27.7K	0.01%	120
2015 Q4	–	Sell	-5,885	Closed	-$320K	–	41
2015 Q3	$320K	Sell	5,885 -720	-11%	-$46.9K	0.27%	53
2015 Q2	$444K	Buy	6,605 +1,413	+27%	+$92.2K	0.3%	43
2015 Q1	$304K	Buy	5,192 +1,836	+55%	+$111K	0.17%	97
2014 Q4	$220K	Buy	+3,356	New	+$212K	0.12%	160

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Texas Capital Bancshares's ABBV Position: Q3 2025 in Review

Texas Capital Bancshares opened a new position in AbbVie (ABBV) in Q3 2025: 136 shares worth $31.5K. The stake represents 0.01% of the portfolio and ranks #120 among its holdings. This is a return to the name: Texas Capital Bancshares previously reported a position in ABBV as recently as Q3 2015.

Texas Capital Bancshares first reported a position in ABBV in Q4 2014 and has held it in 5 quarters since. The position peaked at $444K in Q2 2015. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Texas Capital Bancshares held 136 shares of AbbVie worth $31.5K as of Q3 2025.
AbbVie was a new Texas Capital Bancshares position in Q3 2025.
AbbVie made up 0.01% of Texas Capital Bancshares's portfolio in Q3 2025, its #120 holding.
Texas Capital Bancshares first reported a position in AbbVie in Q4 2014 and has held it in 5 quarters since.
Texas Capital Bancshares's AbbVie position peaked at $444K in Q2 2015.
3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.